FDA Inspection
Symrise AGSymrise AG – FDA Inspection, Mar 9, 2018
Record Details
This FDA Inspection record concerns Symrise AG, with an inspection on March 9, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Jay T. Wong (Issuing Officer)
View Company Profile
ID · dff38aca-8cc2-4e18-8148-c6d0c0017d98
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1046108
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Symrise AG
4| Date | Classification | Office | Project area |
|---|---|---|---|
| December 5, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 7, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 22, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 5, 2013 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
Other documents for Symrise AG
- FDA Inspection 1289898 - 2023-12-05
- FDA Inspection 1135051 - 2020-07-07
- FDA Inspection 968502 - 2016-04-22
- FDA Inspection 818239 - 2013-02-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.